FDA to start new ‘precheck’ program to boost US drug production
The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many pharmaceutical companies have promised to build.
Previous Post
New Vivalink Survey Finds Nearly 90% of Americans Open to Remote Clinical Trials
Next Post
Navigating Tenant-to-Tenant Migrations in Healthcare: 5 Best Practices for a Seamless and Compliant Transition
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago